Umass chan medical school announces research collaboration with moderna to examine impact of cytomegalovirus (cmv) in young children

Study will focus on group childcare and early childhood education settings located in worcester and cambridge to understand transmission and support prevention of cmv worcester, mass. , march 22, 2022 /prnewswire/ -- umass chan medical school today announced a research collaboration with moderna, inc. (nasdaq: mrna), a biotechnology company pioneering messenger rna (mrna)-based therapeutics and vaccines, on a comprehensive study of cytomegalovirus (cmv) transmission in group childcare, education, and household settings.
MRNA Ratings Summary
MRNA Quant Ranking